James LaBelle

16PUBLICATIONS
57CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRespiratory diseasesHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 11, 2026
Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy.

|Apr 26, 2026
Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes.

|Dec 25, 2025
Hospital-mandated restrictions during the COVID-19 pandemic alter hospital-acquired viral respiratory infections during hematopoietic stem cell transplantation: a single center pediatric experience.

Perry Morocco, Madan Kumar, Miranda Foote

|May 29, 2024
Venetoclax Induces BCL-2-Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti-PD-1 Checkpoint Blockade.

Rosy Liao, Jocelyn Y Hsu, Nada S Aboelella

|Sep 09, 2023
Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma.

Mathew R Schnorenberg, Katrina M Hawley, Anika T Thomas-Toth

|Jun 26, 2023
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.

Caner Saygin, Giorgia Giordano, Kathryn Shimamoto

Pageof 3

Frequent Collaborators

3 joint publications

Matthew V Tirrell

3 joint publications

Nada S Aboelella

2 joint publications

Peter A Riedell

2 joint publications

Jun Huang